Ординатура / Офтальмология / Английские материалы / Medical Contact Lens Practice_Millis_2005
.pdf
Index
A
abrasions, corneal scleral lenses 124 staining 51 TCLs 131
absorption, therapeutics 137–8 Acanthamoeba keratitis 66, 70–2
anti-acanthamoebic drugs 142–3 acyclovir 143
adenoviral conjunctivitis 96–7 adherence, lens, EW 88 aftercare, EW 91–2
aging
bifocal contact lenses 39–41 characteristics 36–7
contact lens correction 37–41 corneal edema 37
eyelids 36 monovision 37–9
older patients, evaluation 35–42 presbyopia 37–8, 41
TBUT 37
tear films 36–7
air bubbles, staining 50 allergic conjunctivitis 77–8, 97 allergic eye 75–82
anaphylaxis 76–7 anti-allergy treatment 144–5
atopic keratoconjunctivitis 80–1 contact dermatoblepharitis 81 hypersensitivity 75–7 IgE-mediated (type I)
hypersensitivity 76
immune response modification 80 ocular allergy 77–81
ocular disease 76
T cell-mediated (type IV) hypersensitivity 76–7
vernal keratoconjunctivitis 80, 81
allergic staining 50–1 |
|
bacterial infection 66–70, 85 |
amethocaine 146 |
|
EW 85 |
aminoglycoside antibiotics 141 |
red eye 98–9 |
|
anaphylaxis, allergic eye |
76–7 |
see also contact lens-related |
anesthetics |
|
microbial keratitis |
EW 88 |
|
band keratopathy, TCLs 130 |
topical 146 |
|
basal cell carcinoma (BCC), |
aniridia, prosthetic lenses |
127 |
eyelids 33 |
anterior eye, photography 12–14 |
bielliptical lenses, keratoconus 107 |
|
anterior uveitis, red eye 101 |
bifocal contact lenses |
|
anti-acanthamoebic drugs 142–3 |
aging 39–41 |
|
anti-allergy treatment 144–5 |
aspheric lenses 40–1 |
|
anti-infective drugs 140–3 |
concentric, simultaneous vision |
|
anti-inflammatory drugs 143–5 |
lenses 40–1 |
|
antibiotics 140–2 |
|
modified monovision 41 |
antihistamines 80, 145 |
|
multizone lenses 41 |
antimicrobials 153 |
|
simultaneous vision bifocals 40 |
antivirals 143 |
|
translating (alternating) bifocals |
aphakia |
|
39–40 |
complications 117–18 |
|
bilateral corneal abrasions, TCLs 131 |
EW 117 |
|
blebs, postsurgical 118 |
postsurgical 116–18 |
|
blepharitis 23–4, 31 |
RGP lenses 117 |
|
contact dermatoblepharitis 81 |
soft contact lenses 117 |
|
blinking |
aqueous deficiency, tear films 21 |
deposit formation 54 |
|
aqueous layer, tear films 18 |
dry eye 24–5 |
|
aspheric lenses 40–1 |
|
eyelids 30 |
keratoconus 106–7 |
|
poor 58 |
astigmatism |
|
tear films 18 |
color maps 6 |
|
blood vessels, vascularization 55–7 |
fitting contact lenses 10–12 |
blurred vision |
|
residual, complications 46 |
complications 43–6 |
|
atopic keratoconjunctivitis 80–1 |
EW 87–8 |
|
atropine 146 |
|
bovine spongiform encephalopathy |
azelatine 145 |
|
(BSE) 155 |
|
|
bowtie patterns, corneal topography |
|
|
6–8 |
B |
|
|
|
BSE see bovine spongiform |
|
|
|
encephalopathy |
B cells, immunity 62–3 |
|
bullous keratopathy, TCLs 129–30 |
bacterial conjunctivitis 96 |
burning sensation, complications 46 |
|
C
cancer, eyelids 33
care systems 91–2, 124, 127, 149–56, 160 antimicrobials 153
disinfection 152–3, 154–5 handwashing 149
hydrogen peroxide systems 152–3 lens care 149–56
non-hydrogen peroxide systems 153 rinsing solutions 154
Caroline technique, fitting contact lenses 8–12
cataract, corticosteroids 144
CD lenses, bifocal contact lenses 40–1 cephalosporins 141
chalazia, eyelids 32
chlamydial infection, conjunctivitis 96 chloramphenicol 140–1
choice, lens, factors affecting 2 cicatricial pemphigoid 22 ciprofloxacin 141–2
CLARE see contact lens acute red eye cleaning see care systems
clinical records 157–61 aids 157 confidentiality 159 consultations 160–1
general information 158 good records 157 informed consent 159–60 instruction leaflets 158–9 letters 159
mailing lenses 161 maintaining records 159
practitioner–patient relationship 159 problem-orientated records 158 record data 158
telephone calls 158
clinical slit lamp, photography 12 closed eye 83–5
corneal edema 84–5 hypoxia 83–4
see also extended wear CLPU see contact lens-related
peripheral ulcer
CLRMK see contact lens-related microbial keratitis
CLRPC see contact lens-related papillary conjunctivitis
CN lenses, bifocal contact lenses 40–1 collagen shields
TCLs 133 therapeutics 139
coloboma 3 color maps
astigmatism 6 VKS 5–8
color matching painted lenses, prosthetic lenses 126–7
compliance, therapeutics 140 complications 43–59
astigmatism, residual 46 avoiding 58–9
blurred vision 43–6 burning sensation 46 CLARE 58
corneal edema 43–4
corneal exhaustion syndrome 54–5 damage, lens 45, 51–2
deposit formation 52–4 dirty lenses 45 discomfort 46
EW 87–90 fit, lens 45–6 flare 46–7 glare 46–7
incorrect lenses 44 lens-related problems 51–4 loss, lens 47–8
motivation 57–8 noncompliance 58 pain 46
patient-related problems 57–8 photophobia 47
ruckling 47 signs 44, 48–57 spoilation 52–4 staining 48–51 symptoms 43–8
vascularization 55–7 watering eyes 46
concentric, simultaneous vision lenses 40–1
cone, keratoconus 104–5 confidentiality 159 conjunctivitis
adenoviral 96–7 allergic 77–8, 97 bacterial 96 chlamydial infection 96 features 95–6
GPC 53, 54, 78–80, 124 papillary conjunctivitis 53, 54 pinguecula 97–8
pterygium 98 red eye 95–8
superior limbic keratoconjunctivitis 97
thimerosal sensitivity 97 viral 96–7
conservation, dry eye 26 consultations 160–1
contact dermatoblepharitis 81
contact lens acute red eye (CLARE) 58 contact lens-related acute red eye,
EW 89
contact lens-related microbial keratitis (CLRMK) 61–74
Acanthamoeba keratitis 66, 70–2 clinical features 69–70
corneal alterations 64–5 endothelium changes 64–5 epithelial changes 64, 68–9 etiology 64–5
EW 89
host response 68–9 hypoxia 65 immunity 61–4 investigations 72 management 72 pathogenicity 66–9
protection, ocular surface 61–4 restarting lens wear 72
risk factors 65–6 stromal changes 64 tissue damage 66–9 treatment 72
ulcer formation 69 virulence 66–7
contact lens-related papillary conjunctivitis (CLRPC) 78–80
contact lens-related peripheral ulcer (CLPU), EW 90
corneal abrasions scleral lenses 124 staining 51 TCLs 131
corneal alterations, CLRMK 64–5 corneal desiccation, staining 48–9 corneal edema
aging 37 closed eye 84–5
complications 43–4 EW 84–5
corneal epithelial dystrophies, TCLs 130 corneal erosions, recurrent, TCLs 130–1 corneal exhaustion syndrome 54–5 corneal infiltrates, EW 88–9
corneal inflammation 98–101 corneal sensation 65
corneal staining, keratoconus 108 corneal topography 3–8
keratometry 3–4 patterns 6–8 photokeratoscopy 4 VKS 4–8
corneal vascularization EW 88
see also vascularization corticosteroids 80, 143–4
cataract 144
raised intraocular pressure 144 viral keratitis 99
cranial nerve palsy, TCLs 131 cyclopentolate hydrochloride 145
D
damage, lens, complications 45, 51–2 deposit formation
blinking 54 design, lens 54
environmental drying conditions 54 EW 88
factors affecting 53–4 GPC 53, 54
ionicity 53 “jelly bumps” 53
manufacturing technique 53 mechanism 52–4 medication 54
modality of wear 54 papillary conjunctivitis 53, 54 sulphur 54
types 53
water content 53 dermatochalasis, eyelids 31 Descemet’s membrane, keratoconus
105–6
design, lens, deposit formation 54 digital imaging, photography 13–14 dirty lenses, complications 45 discomfort
complications 46 keratoconus 108 disinfection 152–3, 154–5 see also care systems
displacement, EW 88 distichiasis, eyelashes 31 distribution, therapeutics 138 drops
therapeutics 138–9, 140 wetting drops 147–8
drug delivery TCLs 132
see also therapeutics dry eye 18–27
aqueous tear flow 20 blepharitis 23–4 blinking 24–5 causes 22 classification 19 CLRMK 65, 66 conservation 26
contact lens wear 24–7 defined 18–21 development 26 diagnosis 19–21 evaporative 24–5 eyelid abnormalities 24
grading surface damage 19 hyperosmolarity 26 lubrication 26–7
phenol red thread test 20
preservatives 26 Schirmer’s test 20 stains 19 symptoms 18–19 TBUT 19–21
see also tear films
E
ectropion, eyelids 30–1 edema see corneal edema emedastine 145 endothelium changes
CLRMK 64–5 hypoxia 84
entropion, eyelids 30 environmental drying conditions
deposit formation 54 staining 49
enzyme cleaners 151–2 episcleritis 100 epithelial changes
CLRMK 64, 68–9 hypoxia 84 PEDs 131
TCLs 131
epithelial healing, TCLs 130–1 erosions, recurrent corneal, TCLs 130–1 evaluation, older patients 35–42 evaporative dry eye 24–5
EW see extended wear examination
corneal topography 3–8 EW 86–7
follow-up 14–15 history 1–2 patients 1–12
excretion, therapeutics 138 extended wear (EW) 83–93
adherence, lens 88 aftercare 91–2 anesthetics 88 bacterial infection 85 blurred vision 87–8 closed eye 83–5 CLPU 90
CLRMK 89 complications 87–90
contact lens-related acute red eye 89 corneal edema 84–5
corneal infiltrates 88–9 corneal vascularization 88 deposit formation 88 displacement 88 examination 86–7
fitting contact lenses 86–7 hypoxia 83–4
loss, lens 88
patient information 91 patient selection 85–6
Pseudomonas aeruginosa 85 SEAL 91
silicone hydrogel lenses 90–1 soft lenses 86–7 subepithelial infiltrates 88–9 tear films 85
therapeutic uses 91 eyelashes 29–33
abnormalities 31 distichiasis 31 trichiasis 31
eyelids 29–33 abnormalities, dry eye 24 aging 36
blepharitis 31 blinking 30 cancer 33 chalazia 32
dermatochalasis 31 disorders 31–2 distorted 30–1 ectropion 30–1 entropion 30 ptosis 31
styes 31–2 tension 30 tumors 32–3
F
family history, patients 2 filamentary keratitis, TCLs 130 fit, lens, complications 45–6 fitting contact lenses
astigmatism 10–12 Caroline technique 8–12 EW 86–7
postsurgical 112–14 tear films 8–12 VKS 8–12
fitting scleral lenses 123 fitting TCLs 133
flare, complications 46–7 Fleischer’s ring, keratoconus 105 fluorescein stain 147
dry eye 19, 20 fluoroquinolones 141–2 follow-up examination 14–15 foreign body staining 49 fornices, TCLs 132
fusidic acid 142
G
gels, therapeutics 139 gentamicin 141
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
giant papillary conjunctivitis (GPC) |
|
inferior arcuate staining 49 |
|
surgery 107–8 |
|
|
78–80 |
|
infiltrates, corneal, EW 88–9 |
|
visual acuity 104 |
|
|
deposit formation 53, 54 |
|
inflammation |
|
Vogt’s striae 105 |
|
|
scleral lenses 124 |
|
corneal 98–101 |
|
keratometry 3–4 |
|
|
glare, complications 46–7 |
|
see also conjunctivitis; red eye |
|
automated 4 |
|
|
glaucoma, PACG 101 |
|
informed consent 159–60 |
|
keratoses, eyelids 32 |
|
|
GPC see giant papillary conjunctivitis |
|
initial visit, patients 1–2 |
|
|
|
|
graft rejection, postsurgical 114 |
|
instruction leaflets 158–9 |
|
|
|
|
|
|
L |
|
||
|
|
|
international organization for |
|
|
|
|
|
|
standardization (ISO), materials |
|
|
|
|
H |
|
lacerations, TCLs 132 |
|
||
|
|
classification 25 |
|
|
||
|
|
|
ionicity, deposit formation 53 |
|
lacrimal system 29–33 |
|
|
handpainted lenses, prosthetic lenses |
|
iris prolapses, postsurgical 118 |
|
watering eyes 32 |
|
|
126 |
|
irregular pattern, corneal topography |
|
laminated lenses, prosthetic lenses 125 |
|
|
handwashing 149 |
|
6–8 |
|
laser assisted in-situ keratomileusis |
|
|
hay fever 77–8 |
|
ISO see international organization for |
|
(LASIK) 115 |
|
|
Herpes simplex 99 |
|
standardization |
|
lens care 91–2, 124, 127, 149–50, 149–56 |
|
|
Herpes zoster 100 |
|
|
|
lens-related problems, complications |
|
|
history |
|
|
|
51–4 |
|
|
|
J |
|
|||
|
keratoconus 104 |
|
|
letters 159 |
|
|
|
patients 1–2, 35–6 |
|
|
|
levocabastine 145 |
|
|
hybrid lenses, postsurgical 113 |
|
“jelly bumps”, deposit formation 53 |
|
lignocaine 146 |
|
|
hydration, TCLs 131 |
|
|
|
lipid deposits 53 |
|
|
hydrogel lenses |
|
|
|
lipid layer, tear films 17–18 |
|
|
|
K |
|
|||
|
EW 90–1 |
|
|
Lissamine green stain 147 |
|
|
|
keratoconus 107 |
|
|
|
dry eye 19 |
|
|
TCLs 132 |
|
Kaposi’s sarcoma, eyelids 33 |
|
lodoxamide 144 |
|
|
therapeutic uses 91 |
|
keratitis see Acanthamoeba keratitis; |
|
loss, lens |
|
|
hydrogen peroxide systems 152–3 |
|
contact lens-related microbial |
|
complications 47–8 |
|
|
hyperosmolarity, dry eye 26 |
|
keratitis; filamentary keratitis; |
|
EW 88 |
|
|
hypersensitivity, allergic eye 75–7 |
|
rosacea keratitis; Thygeson’s |
|
lubricants 147–8 |
|
|
hypoxia |
|
superficial punctate keratitis; |
|
lubrication, dry eye 26–7 |
|
|
closed eye 83–4 |
|
viral keratitis |
|
|
|
|
CLRMK 65 |
|
keratoconus 103–9 |
|
|
|
|
|
|
M |
|
||
|
endothelial changes 84 |
|
aspheric lenses 106–7 |
|
|
|
|
epithelial changes 84 |
|
bielliptical lenses 107 |
|
|
|
|
EW 83–4 |
|
clinical findings 104–6 |
|
mailing lenses 161 |
|
|
scleral lenses 124 |
|
complications 108 |
|
malignant melanoma, eyelids 33 |
|
|
stromal changes 84 |
|
cone 104–5 |
|
MALT see mucosa-associated lymphoid |
|
|
tear films 85 |
|
corneal staining 108 |
|
tissue |
|
|
|
|
Descemet’s membrane 105–6 |
|
manufacturing technique, deposit |
|
|
|
|
discomfort 108 |
|
formation 53 |
|
|
I |
|
||||
|
|
etiology 104 |
|
mast cell stabilizers 80, 144 |
|
|
|
|
|
examination 3 |
|
materials classification, ISO 25 |
|
|
IgE-mediated (type I) hypersensitivity, |
|
Fleischer’s ring 105 |
|
medical history, patients 2 |
|
|
allergic eye 76 |
|
histopathology 103 |
|
medication |
|
|
Igs see immunoglobulins |
|
history 104 |
|
deposit formation 54 |
|
|
image capture, photography 13–14 |
|
management 106–8 |
|
TCLs 134 |
|
|
immunity |
|
Munson’s sign 106 |
|
see also therapeutics |
|
|
B cells 62–3 |
|
pathogenesis 104 |
|
meibomian gland disease (MGD) 23 |
|
|
CLRMK 61–4 |
|
personality 104 |
|
metabolism, therapeutics 138 |
|
|
Igs 62–3 |
|
piggyback lenses 107 |
|
MGD see meibomian gland disease |
|
|
MALT 63–4 |
|
Rizzuli’s sign 106 |
|
modality of wear, deposit formation 54 |
|
|
modification, immune response 80 |
|
Rose K lens 107 |
|
modified monovision, bifocal contact |
|
|
phagocytes 63 |
|
scars, raised nodular 108 |
|
lenses 41 |
|
|
T cells 63 |
|
soft hydrogel lenses 107 |
|
molding, TCLs 132 |
|
|
see also allergic eye |
|
softperm lenses 107 |
|
monovision, aging 37–9 |
|
|
immunoglobulins (Igs) 62–3 |
|
spherical lenses 106 |
|
motivation, complications 57–8 |
|
|
incorrect lenses, complications 44 |
|
staining 108 |
|
mucin balls, staining 50 |
|
|
|
|
|
|
mucosa-associated lymphoid tissue |
patients |
color matching painted lenses 126– |
|
(MALT), immunity 63–4 |
examination 1–12 |
complications 127–8 |
|
mucus deficiency, tear films 21–2 |
family history 2 |
handpainted lenses 126 |
|
mucus layer, tear films 18 |
history 1–2, 35–6 |
indications 125 |
|
multizone lenses, bifocal contact |
initial visit 1–2 |
laminated lenses 125 |
|
lenses 41 |
medical history 2 |
lens care 127 |
|
Munson’s sign, keratoconus 106 |
older patients, evaluation 35–42 |
lens selection 125–7 |
|
mydriatics 145–6 |
practitioner–patient relationship 159 |
occlusive black pupils 126 |
|
|
PEDs see persistent epithelial defects |
offset lenses 126 |
|
|
perennial allergic conjunctivitis (PAC) |
patient management 127 |
|
N |
||
|
77–8 |
printed lenses 125 |
|
|
|
perforations, TCLs 132 |
RGP lenses 127 |
|
nedocromil 144 |
permeability, oxygen 25 |
scleral shell 127 |
|
neomycin 141 |
peroxide systems 152–3 |
protection |
|
neovascularization, scleral lenses 124 |
persistent epithelial defects (PEDs), |
CLRMK 61–4 |
|
nevi, eyelids 32–3 |
TCLs 131 |
TCLs 131–2 |
|
nomenclature, therapeutics 138 |
personality, keratoconus 104 |
proxymetacaine 146 |
|
noncompliance, complications 58 |
phagocytes, immunity 63 |
Pseudomonas aeruginosa |
|
nonsteroidal anti-inflammatory drugs |
pharmacokinetics 137–40 |
CLRMK, clinical features 66–70 |
|
(NSAIDs) 144 |
pharmacology 137–48 |
EW 85 |
|
|
phenol red thread test, dry eye 20 |
pterygium, conjunctivitis 98 |
|
|
photo slit-lamp biomicrography 12–13 |
ptosis |
|
O |
||
|
photography |
eyelids 31 |
|
|
|
anterior eye 12–14 |
TCLs 132 |
|
occlusive black pupils, prosthetic |
clinical slit lamp 12 |
|
|
lenses 126 |
digital imaging 13–14 |
|
|
R |
||
|
ocular allergy 77–81 |
image capture 13–14 |
|
|
ocular decongestants 145 |
photo slit-lamp biomicrography |
|
|
ocular disease, allergic eye 76 |
12–13 |
radial keratotomy (RK) 115–16 |
|
offset lenses, prosthetic lenses 126 |
Polaroid® cameras 12 |
raised intraocular pressure, |
|
ofloxacin 142 |
single lens reflex cameras 12 |
corticosteroids 144 |
|
ointments, therapeutics 139 |
slit-lamp biomicrography 12–13 |
rasterstereography, VKS 5 |
|
older patients, evaluation 35–42 |
photokeratoscopy 4 |
record keeping see clinical records |
|
olopatidine (Opatanol®) 145 |
photophobia, complications 47 |
recurrent corneal erosions, TCLs 130–1 |
|
opacities, lens 3 |
photorefractive keratectomy 114–15 |
red eye |
|
Otrivine Antistin® 145 |
piggyback lenses |
anterior uveitis 101 |
|
oval pattern, corneal topography 6–8 |
keratoconus 107 |
bacterial infection 98–9 |
|
oxybuprocaine 146 |
postsurgical 113 |
conjunctival inflammation 95–8 |
|
oxygen permeability 25 |
pinguecula, conjunctivitis 97–8 |
contact lens-related acute red eye 8 |
|
|
PMMA see polymethylmethacrylate |
corneal inflammation 98–101 |
|
|
lenses |
differential diagnosis 95–102 |
|
P |
||
|
Polaroid® cameras 12 |
episcleritis 100 |
|
|
|
polyhexamethylene biguanide 143 |
PACG 101 |
|
PAC see perennial allergic |
polymethylmethacrylate (PMMA) |
rosacea keratitis 100 |
|
conjunctivitis |
lenses |
scleral lenses 124 |
PACG see primary angle-closure |
corneal edema 43–4 |
scleritis 100–1 |
|
|
glaucoma |
examination 3 |
uveitis 101 |
pain, complications 46 |
postkeratoplasty contact lenses 111–12 |
viral keratitis 99–100 |
|
pain relief, TCLs 129–30 |
postsurgical contact lenses 111–19 |
see also conjunctivitis |
|
palpebral aperture 29–30 |
practitioner–patient relationship 159 |
reflection-based systems, VKS 4–5 |
|
papillary conjunctivitis 78–80 |
presbyopia, aging 37–8, 41 |
refractive surgery 114–16 |
|
|
deposit formation 53, 54 |
preservatives, dry eye 26 |
LASIK 115 |
patient advice, postsurgical 114 |
primary angle-closure glaucoma |
photorefractive keratectomy 114–1 |
|
patient information, EW 91 |
(PACG) 101 |
RK 115–16 |
|
patient management, prosthetic lenses |
printed lenses, prosthetic lenses 125 |
Reis–Buckler’s corneal dystrophy, |
|
127 |
prodrug, therapeutics 139 |
TCLs 131 |
|
patient-related problems, |
propamidine isethionate 143 |
RGP lenses |
|
|
complications 57–8 |
prosthetic lenses 125–8 |
aphakia 117 |
patient selection, EW 85–6 |
aniridia 127 |
prosthetic lenses 127 |
|
|
|
|
|
RGP lenses (contd) |
therapeutics 139 |
aphakia 116–18 |
|
surgery 112–13 |
soft hydrogel lenses, keratoconus 107 |
blebs 118 |
|
TCLs 132–3 |
softperm lenses, keratoconus 107 |
fitting contact lenses 112–14 |
|
tisilfocon 91 |
solutions, lens |
graft rejection 114 |
|
rinsing solutions 154 |
bottles 154 |
hybrid lenses 113 |
|
risk minimization, TCLs 134 |
CLRMK 66 |
iris prolapses 118 |
|
Rizzuli’s sign, keratoconus 106 |
provision 155 |
keratoconus 107–8 |
|
RK see radial keratotomy |
rinsing solutions 153–4 |
LASIK 115 |
|
rodent ulcer (BCC), eyelids 33 |
see also care systems |
patient advice 114 |
|
rosacea keratitis 100 |
SPEE see superficial punctate |
piggyback lenses 113 |
|
Rose Bengal stain 147 |
epithelial erosions |
postkeratoplasty contact lenses |
|
dry eye 19 |
spherical lenses, keratoconus 106 |
111–12 |
|
Rose K lens, keratoconus 107 |
SPK see superficial punctate keratitis |
postsurgical contact lenses 111–19 |
|
round pattern, corneal topography 6–8 |
splinting, TCLs 132 |
presurgical fitting 118 |
|
ruckling, complications 47 |
spoilation, complications 52–4 |
refractive 114–16 |
|
|
sport, scleral lenses 122 |
RGP lenses 112–13 |
|
|
squamous cell carcinoma, eyelids 33 |
soft contact lenses 113 |
|
S |
|||
staining |
TCLs 131–2 |
||
|
abrasions, corneal 51 |
|
|
SAC see seasonal allergic conjunctivitis |
air bubbles 50 |
|
|
T |
|||
scars, raised nodular, keratoconus 108 |
allergic 50–1 |
||
Schirmer’s test, dry eye 20 |
causes 48–51 |
|
|
scleral lenses 121–5 |
complications 48–51 |
T cell-mediated (type IV) |
|
advantages 122–3 |
corneal abrasions 51 |
hypersensitivity, allergic eye 76–7 |
|
checking 123–4 |
corneal desiccation 48–9 |
T cells, immunity 63 |
|
complications 124 |
corneal, keratoconus 108 |
TBUT see tear film break-up time |
|
corneal abrasions 124 |
dry eye 19–20 |
TCLs see therapeutic contact lenses |
|
disadvantages 122–3 |
environmental drying conditions 49 |
teaching appointment 14 |
|
exposure keratopathy 124 |
foreign body 49 |
tear film break-up time (TBUT) 19–21 |
|
fitting 123 |
inferior arcuate 49 |
aging 37 |
|
frothing 124 |
keratoconus 108 |
assessment 20 |
|
GPC 124 |
mechanical causes 49–50 |
FTBUT 20 |
|
hypoxia 124 |
mucin balls 50 |
NIBUT 20 |
|
indications 121–2 |
SEAL 49, 50 |
tear films |
|
lens care 124 |
SPEE 48 |
aging 36–7 |
|
mucus 124 |
SPK 48, 51 |
aqueous deficiency 21 |
|
neovascularization 124 |
three and nine o’clock 48–9 |
aqueous layer 18 |
|
red eye 124 |
tight lens fit 49–50 |
assessment 17–27 |
|
sport 122 |
toxic 50–1 |
blepharitis 23–4 |
|
therapeutic uses 122 |
trapped air bubbles 50 |
blinking 18 |
|
ventilation 123 |
types 48 |
contact lens wear 24–7 |
|
scleral shell, prosthetic lenses 127 |
vital dyes 147 |
disorders 21–5 |
|
scleritis 100–1 |
staphylococcal blepharitis 23 |
dry eye 18–27 |
|
SEAL see superior epithelial arcuate |
steroids see corticosteroids |
EW 85 |
|
staining |
stromal changes |
fitting contact lenses 8–12 |
|
seasonal allergic conjunctivitis (SAC) |
CLRMK 64 |
hypoxia 85 |
|
77, 78 |
hypoxia 84 |
lipid layer 17–18 |
|
seborrheic blepharitis 23 |
styes, eyelids 31–2 |
mucus deficiency 21–2 |
|
silicone hydrogel lenses |
subepithelial infiltrates, EW 88–9 |
mucus layer 18 |
|
EW 90–1 |
sulphur, deposit formation 54 |
osmolality 21 |
|
therapeutic uses 91 |
superficial punctate epithelial erosions |
Sjögren’s disease 21, 22 |
|
silicone rubber lenses, TCLs 133 |
(SPEE), staining 48, 51 |
structure 17–18 |
|
simultaneous vision bifocals 40 |
superficial punctate keratitis (SPK) 48 |
tear film meniscus 20–1 |
|
single lens reflex cameras 12 |
superior epithelial arcuate staining |
tear film turnover 20 |
|
Sjögren’s disease 21, 22 |
(SEAL) 49, 50 |
unstable 18 |
|
slit-lamp biomicrography 12–13 |
EW 91 |
see also dry eye |
|
sodium cromoglycate 144 |
superior limbic keratoconjunctivitis 97 |
telephone calls 158 |
|
soft contact lenses |
TCLs 130 |
terminology, contact lenses 65 |
|
postsurgical 113 |
surgery |
tetracyclines 142 |
therapeutic contact lenses (TCLs) 129–35
band keratopathy 130 bilateral corneal abrasions 131 bullous keratopathy 129–30 collagen shields 133 complications 134 contraindications 134
corneal abrasions 131
corneal epithelial dystrophies 130 cranial nerve palsy 131
drug delivery 132 epithelial changes 131 epithelial healing 130–1 filamentary keratitis 130 fitting 133
fornices 132 hydration 131 hydrogel lenses 132 lacerations 132
lens selection 132–3 management 133 medication 134 molding 132
pain relief 129–30 PEDs 131 perforations 132 postsurgical 131–2 protection 131–2 ptosis 132
recurrent corneal erosions 130–1 Reis–Buckler’s corneal dystrophy
131
RGP lenses 132–3 risk minimization 134
silicone rubber lenses 133 splinting 132
superior limbic keratoconjunctivitis 130
Thygeson’s superficial punctate keratitis 130
therapeutic uses EW 91
scleral lenses 122
silicone hydrogel lenses 91 therapeutics 137–48
absorption 137–8 acyclovir 143 amethocaine 146
aminoglycoside antibiotics 141 anti-acanthamoebic drugs 142–3 anti-allergy treatment 144–5 anti-infective drugs 140–3 anti-inflammatory drugs 143–5 antibiotics 140–2
antihistamines 80, 145 antivirals 143 atropine 146 azelatine 145
cephalosporins 141 chloramphenicol 140–1 ciprofloxacin 141–2 collagen shields 139 compliance 140 corticosteroids 143–4
cyclopentolate hydrochloride 145 distribution 138
drops 138–9, 140
drug delivery, TCLs 132 drug delivery vehicles 138–9 emedastine 145
excretion 138 fluoroquinolones 141–2 fusidic acid 142
gels 139 gentamicin 141 levocabastine 145 lignocaine 146 lodoxamide 144 lubricants 147–8
mast cell stabilizers 80, 144 mechanisms of action 140 metabolism 138 mydriatics 145–6 nedocromil 144
neomycin 141 nomenclature 138 NSAIDs 144
ocular decongestants 145 ofloxacin 142
ointments 139
olopatidine (Opatanol®) 145 Otrivine Antistin® 145 oxybuprocaine 146 pharmacokinetics 137–40 polyhexamethylene biguanide 143 prodrug 139
propamidine isethionate 143 proxymetacaine 146
sodium cromoglycate 144 soft contact lenses 139 tetracyclines 142 tobramycin 141
topical anesthetics 146 trifluorothymidine (F3T) 143 tropicamide 146
vehicles, drug delivery 138–9 vital dyes 147
wetting drops 147–8
thimerosal sensitivity, conjunctivitis 97 three and nine o’clock staining 48–9 Thygeson’s superficial punctate
keratitis, TCLs 130 tight lens fit, staining 49–50 tisilfocon RGP lenses 91 tobramycin 141
tonometers, disinfection 154–5 topical anesthetics 146
complications 146 topography, corneal see corneal
topography toxic staining 50–1
translating (alternating) bifocals 39–40 trapped air bubbles, staining 50 trichiasis, eyelashes 31 trifluorothymidine (F3T) 143 tropicamide 146
tumors, eyelids 32–3
U
uveitis, red eye 101
V
vascularization causes 55
complications 55–7 EW 88 management 55–7
neovascularization 124 scleral lenses 124
vehicles, drug delivery 138–9 ventilation, scleral lenses 123 vernal keratoconjunctivitis 80, 81 videokeratoscopy (VKS) 4–12
color maps 5–8
corneal topography 4–8 fitting contact lenses 8–12 projection-based systems 5–8 rasterstereography 5 reflection-based systems 4–5
viral conjunctivitis 96–7 antivirals 143
viral keratitis 99–100
visual acuity, keratoconus 104 vital dyes 147
VKS see videokeratoscopy Vogt’s striae, keratoconus 105
W
water content, deposit formation 53 water, tap, CLRMK 66
watering eyes complications 46 lacrimal system 32
wetting drops 147–8
X
xanthelasma, eyelids 33
